Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Wednesday, October 14, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

What private practices, hospitals and investors should know about the M&A market in cardiology

William Holding, a veteran healthcare consultant, spoke to Cardiovascular Business about the ever-changing cardiology industry. Should private practices seek a deal or stay independent? How has private equity impacted the market? He answered those questions and many more. 

READ MORE >
business people
Share on Twitter Share on Facebook Share on Linkedin

What private practices, hospitals and investors should know about the M&A market in cardiology

Share on Twitter Share on Facebook Share on Linkedin
business people
William Holding, a veteran healthcare consultant, spoke to Cardiovascular Business about the ever-changing cardiology industry. Should private practices seek a deal or stay independent? How has private equity impacted the market? He answered those questions and many more. 
READ MORE >

Safer, faster, more effective: Why cardiac PET should be the primary nuclear modality

Rick Snyder, MD, president of the Cardiac PET Alliance, says PET offers better images than SPECT and is associated with much less radiation.

READ MORE >
Rick Snyder, MD, FACC, president of the Cardiac PET Alliance, president of HeartPlace and chief physician executive at U.S. Heart and Vascular, spoke with Cardiovascular Business in the above video interview. He said the organization is working with lawmakers and healthcare systems to expand access to cardiac PET. The effort also aims to educate government and commercial payers about the technology's potential to improve patient care while reducing overall healthcare costs.
Share on Twitter Share on Facebook Share on Linkedin

Safer, faster, more effective: Why cardiac PET should be the primary nuclear modality

Share on Twitter Share on Facebook Share on Linkedin
Rick Snyder, MD, FACC, president of the Cardiac PET Alliance, president of HeartPlace and chief physician executive at U.S. Heart and Vascular, spoke with Cardiovascular Business in the above video interview. He said the organization is working with lawmakers and healthcare systems to expand access to cardiac PET. The effort also aims to educate government and commercial payers about the technology's potential to improve patient care while reducing overall healthcare costs.
Rick Snyder, MD, president of the Cardiac PET Alliance, says PET offers better images than SPECT and is associated with much less radiation.
READ MORE >

Physicians support Medicare coverage for TAVR in patients with aortic regurgitation

The ACC, SCAI and STS have shared early support for expanding Medicare coverage to include TAVR in patients with native AR. The groups emphasized that CED requirements and multidisciplinary heart team meetings are necessary to ensure patients receive the best possible care going forward.

READ MORE >
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Share on Twitter Share on Facebook Share on Linkedin

Physicians support Medicare coverage for TAVR in patients with aortic regurgitation

Share on Twitter Share on Facebook Share on Linkedin
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
The ACC, SCAI and STS have shared early support for expanding Medicare coverage to include TAVR in patients with native AR. The groups emphasized that CED requirements and multidisciplinary heart team meetings are necessary to ensure patients receive the best possible care going forward.
READ MORE >

Featured Articles

Sutureless aortic valve linked to positive 7-year data

The next-generation surgical device from Corcym was associated with consistent durability and positive safety data. For example, freedom from structural valve deterioration was seen in 99.7% of patients.

READ MORE >
Corcym’s Perceval Plus aortic heart valve
Share on Twitter Share on Facebook Share on Linkedin

Sutureless aortic valve linked to positive 7-year data

Share on Twitter Share on Facebook Share on Linkedin
Corcym’s Perceval Plus aortic heart valve
The next-generation surgical device from Corcym was associated with consistent durability and positive safety data. For example, freedom from structural valve deterioration was seen in 99.7% of patients.
READ MORE >

JenaValve recalls certain TAVR delivery catheters over safety concerns

This Class II recall was initiated due to a risk of clinicians encountering issues when deploying the Trilogy Transcatheter Heart Valve System. 

READ MORE >
FDA recall medical device recall product recall
Share on Twitter Share on Facebook Share on Linkedin

JenaValve recalls certain TAVR delivery catheters over safety concerns

Share on Twitter Share on Facebook Share on Linkedin
FDA recall medical device recall product recall
This Class II recall was initiated due to a risk of clinicians encountering issues when deploying the Trilogy Transcatheter Heart Valve System. 
READ MORE >

Siemens Healthineers doubles down on cardiovascular care as it exits general imaging ultrasound business

The healthcare giant's shift in strategy puts an increased focus on systems used by electrophysiologists and interventional cardiologists to manage and treat cardiovascular disease.

READ MORE >
man making a decision
Share on Twitter Share on Facebook Share on Linkedin

Siemens Healthineers doubles down on cardiovascular care as it exits general imaging ultrasound business

Share on Twitter Share on Facebook Share on Linkedin
man making a decision
The healthcare giant's shift in strategy puts an increased focus on systems used by electrophysiologists and interventional cardiologists to manage and treat cardiovascular disease.
READ MORE >

Thousands of New York heart patients may lose access to care—state senator asks governor to intervene

Cardiology services for approximately 50,000 patients are in the middle of an ongoing legal battle. New York Sen. Jim Tedisco is now publicly calling for New York. Gov. Kathy Hochul to step in and help. 

READ MORE >
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
Share on Twitter Share on Facebook Share on Linkedin

Thousands of New York heart patients may lose access to care—state senator asks governor to intervene

Share on Twitter Share on Facebook Share on Linkedin
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
Cardiology services for approximately 50,000 patients are in the middle of an ongoing legal battle. New York Sen. Jim Tedisco is now publicly calling for New York. Gov. Kathy Hochul to step in and help. 
READ MORE >

Lab-grown coronary bypass graft still working well 2 years after implantation

The experimental technology could help clinicians perform CABG procedures without needing to harvest vessels from the patient.

READ MORE >
Vascudyne off-the-shelf bioengineered blood vessel for CABG two-year results presented at EACTS 2026.
Share on Twitter Share on Facebook Share on Linkedin

Lab-grown coronary bypass graft still working well 2 years after implantation

Share on Twitter Share on Facebook Share on Linkedin
Vascudyne off-the-shelf bioengineered blood vessel for CABG two-year results presented at EACTS 2026.
The experimental technology could help clinicians perform CABG procedures without needing to harvest vessels from the patient.
READ MORE >

In Case You Missed It

FDA approves first sirolimus drug-eluting balloon for in-stent restenosis

The newly approved device from Cordis provides therapy over an extended period of time without leaving a permanent implant behind.

READ MORE >
 The U.S. Food and Drug Administration (FDA) has cleared the Cordis Selution SLR (Sustained Limus Release) Drug-Eluting Balloon (DEB) for the treatment of coronary in-stent restenosis (ISR). With this market approval, Cordis is entering the coronary drug-coated balloon market. The device is also the first sirolimus DEB cleared in the U.S.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first sirolimus drug-eluting balloon for in-stent restenosis

Share on Twitter Share on Facebook Share on Linkedin
 The U.S. Food and Drug Administration (FDA) has cleared the Cordis Selution SLR (Sustained Limus Release) Drug-Eluting Balloon (DEB) for the treatment of coronary in-stent restenosis (ISR). With this market approval, Cordis is entering the coronary drug-coated balloon market. The device is also the first sirolimus DEB cleared in the U.S.
The newly approved device from Cordis provides therapy over an extended period of time without leaving a permanent implant behind.
READ MORE >

AI uses routine CT images to evaluate cardiovascular risk

Researchers have trained a new AI model to read routine medical images and deliver accurate cardiovascular age assessments.

READ MORE >
artificial intelligence AI heart cardiology
Share on Twitter Share on Facebook Share on Linkedin

AI uses routine CT images to evaluate cardiovascular risk

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI heart cardiology
Researchers have trained a new AI model to read routine medical images and deliver accurate cardiovascular age assessments.
READ MORE >

Cardiologist impaled by tree branch makes a full recovery

The doctor, visiting Montana from Pennsylvania for a ski trip, says he did not even realize at first what had happened.

READ MORE >
Skiing
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist impaled by tree branch makes a full recovery

Share on Twitter Share on Facebook Share on Linkedin
Skiing
The doctor, visiting Montana from Pennsylvania for a ski trip, says he did not even realize at first what had happened.
READ MORE >

In Other News

Insurer files lawsuit as CMS releases 2027 Medicare Advantage star ratings

Despite six of its seven contracts earning over 4 stars, Alignment Health is challenging the Centers for Medicare & Medicaid Services’ methodology.

READ MORE >
quality excellence star stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Insurer files lawsuit as CMS releases 2027 Medicare Advantage star ratings

Share on Twitter Share on Facebook Share on Linkedin
quality excellence star stethoscope
Despite six of its seven contracts earning over 4 stars, Alignment Health is challenging the Centers for Medicare & Medicaid Services’ methodology.
READ MORE >

House bill would eliminate NSA arbitration, align payments between payers and providers

The “Lower Premiums, Faster Payments Act” from Rep. Frank Pallone (D-NJ) would eliminate the independent dispute process completely. Its proposal comes after recent indication that the No Surprises Act lacks teeth.

READ MORE >
Healthcare salaries and compensation
Share on Twitter Share on Facebook Share on Linkedin

House bill would eliminate NSA arbitration, align payments between payers and providers

Share on Twitter Share on Facebook Share on Linkedin
Healthcare salaries and compensation
The “Lower Premiums, Faster Payments Act” from Rep. Frank Pallone (D-NJ) would eliminate the independent dispute process completely. Its proposal comes after recent indication that the No Surprises Act lacks teeth.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
TAVR accessories recalled | A new ultrasound strategy | Lab-grown graft delivers | Sutureless heart valves | Coverage concerns
News Alert: Siemens Healthineers doubles down on cardiovascular care as it exits general imaging ultrasound business
The best hospitals in the world for heart surgery | More momentum for AI-powered CCTA tools | Peripheral IVL vs. atherectomy
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup